ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01715818
Brief Title: A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities

First Submitted : October 25, 2012
First Submitted that Met QC Criteria : October 25, 2012
First Posted : October 29, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : November 1, 2016
Last Update Posted : November 2, 2016 (Estimate)